Charles A. Vacanti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Charles A. Vacanti has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Koji Kojima
Department of Anesthesiology, Laboratory for Tissue Engineering and Regenerative Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts
2 shared publicationsAndreas H. Gomoll
Department of Orthopedic Surgery, Cartilage Repair Center, Harvard Medical School, Brigham and Women's Hospital, Chestnut Hill, Massachusetts
1 shared publication- Ashley Penvose
Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA
1 shared publication Ashley R. Penvose
Department of Anesthesiology, Laboratory for Tissue Engineering and Regenerative Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts
1 shared publication- Giovanni Maio
Albert-Ludwigs-Universität Freiburg
1 shared publication Haruko Obokata
Department of Anesthesiology, Laboratory for Tissue Engineering and Regenerative Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts
1 shared publication
Latest Publications
- 1 December 2012
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 18 (23-24) , 2549-2558
Effect on Ligament Marker Expression by Direct-Contact Co-culture of Mesenchymal Stem Cells and Anterior Cruciate Ligament Cells
Ligament and tendon repair is an important topic in orthopedic tissue engineering; however, the cell source for tissue regeneration has been a controversial issue. Until now, scientists have been split between the use of primary ligament fibroblasts or marrow-derived mesenchymal stem cells (MSCs). The objective of this study was to show that a co-culture of anterior cruciate ligament (ACL) cells and MSCs has a beneficial effect on ligament regeneration that is not observed when utilizing either cell source independently. Autologous ACL cells (ACLcs) and MSCs were isolated from Yorkshire pigs, expanded in vitro, and cultured in multiwell plates in varying %ACLcs/%MSCs ratios (100/0, 75/25, 50/50, 25/75, and 0/100) for 2 and 4 weeks. Quantitative mRNA expression analysis and immunofluorescent staining for ligament markers Collagen type I (Collagen-I), Collagen type III (Collagen-III), and Tenascin-C were performed. We show that Collagen-I and Tenascin-C expression is significantly enhanced over time in 50/50 co-cultures of ACLcs and MSCs (p≤0.03), but not in other groups. In addition, Collagen-III expression was significantly greater in MSC-only cultures (p≤0.03), but the Collagen-I-to-Collagen-III ratio in 50% co-culture was closest to native ligament levels. Finally, Tenascin-C expression at 4 weeks was significantly higher (p≤0.02) in ACLcs and 50% co-culture groups compared to all others. Immunofluorescent staining results support our mRNA expression data. Overall, 50/50 co-cultures had the highest Collagen-I and Tenascin-C expression, and the highest Collagen-I-to-Collagen-III ratio. Thus, we conclude that using a 50% co-culture of ACLcs and MSCs, instead of either cell population alone, may better maintain or even enhance ligament marker expression and improve healing.
- 1 December 2012
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 18 (23-24) , 2549-2558
Effect on Ligament Marker Expression by Direct-Contact Co-culture of Mesenchymal Stem Cells and Anterior Cruciate Ligament Cells
Ligament and tendon repair is an important topic in orthopedic tissue engineering; however, the cell source for tissue regeneration has been a controversial issue. Until now, scientists have been split between the use of primary ligament fibroblasts or marrow-derived mesenchymal stem cells (MSCs). The objective of this study was to show that a co-culture of anterior cruciate ligament (ACL) cells and MSCs has a beneficial effect on ligament regeneration that is not observed when utilizing either cell source independently. Autologous ACL cells (ACLcs) and MSCs were isolated from Yorkshire pigs, expanded in vitro, and cultured in multiwell plates in varying %ACLcs/%MSCs ratios (100/0, 75/25, 50/50, 25/75, and 0/100) for 2 and 4 weeks. Quantitative mRNA expression analysis and immunofluorescent staining for ligament markers Collagen type I (Collagen-I), Collagen type III (Collagen-III), and Tenascin-C were performed. We show that Collagen-I and Tenascin-C expression is significantly enhanced over time in 50/50 co-cultures of ACLcs and MSCs (p≤0.03), but not in other groups. In addition, Collagen-III expression was significantly greater in MSC-only cultures (p≤0.03), but the Collagen-I-to-Collagen-III ratio in 50% co-culture was closest to native ligament levels. Finally, Tenascin-C expression at 4 weeks was significantly higher (p≤0.02) in ACLcs and 50% co-culture groups compared to all others. Immunofluorescent staining results support our mRNA expression data. Overall, 50/50 co-cultures had the highest Collagen-I and Tenascin-C expression, and the highest Collagen-I-to-Collagen-III ratio. Thus, we conclude that using a 50% co-culture of ACLcs and MSCs, instead of either cell population alone, may better maintain or even enhance ligament marker expression and improve healing.
- 1 July 2010
- Published by Elsevier in Experimental Cell Research
- Vol. 316 (12) , 1966-1976
Adult muscle ‘stem’ cells can be sustained in culture as free-floating myospheres
- 1 July 2010
- Published by Elsevier in Experimental Cell Research
- Vol. 316 (12) , 1966-1976
Adult muscle ‘stem’ cells can be sustained in culture as free-floating myospheres
- Open Access
- 9 August 2008
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 12 (5b) , 1785-1793
ETHICAL ISSUES IN CELLULAR AND MOLECULAR MEDICINE AND TISSUE ENGINEERING
- 9 August 2008
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 12 (5b) , 1785-1793
Open AccessETHICAL ISSUES IN CELLULAR AND MOLECULAR MEDICINE AND TISSUE ENGINEERING
- 14 April 2008
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 206 (6) , 1095-1096
Tissue Engineering: Where Are We Headed?
- 14 April 2008
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 206 (6) , 1095-1096
Tissue Engineering: Where Are We Headed?
- Open Access
- 1 July 2006
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 10 (3) , 569-576
The history of tissue engineering
- 1 July 2006
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 10 (3) , 569-576
Open AccessThe history of tissue engineering
- 1 June 2004
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 39 (3) , 257-262
Generation of a tissue‐engineered tracheal equivalent
In this Minireview we summarize efforts to generate an autologous tissue‐engineered trachea (TET) shaped as a cylinder containing a helix of cartilage to form the structural component of a functional tracheal replacement. Our first step was to demonstrate that a composite engineered tracheal equivalent composed of cartilaginous cylinder could be lined with nasal epithelial cells in a nude‐mouse model. We then demonstrated the feasibility of creating the cartilage and fibrous portion of the trachea using autologous tissue harvested from a single procedure in both nude‐rat and sheep models. Gross morphology and tissue morphology of these TET series were similar to that of native trachea. Histological data indicated the presence of mature cartilage formation of a pseudostratified columnar epithelium and the presence of mature cartilage surrounded by connective tissue, as would be expected of native trachea. Regarding the biomechanical properties, the cartilage was excellent in nude model; however, sheep autologous TET provided less support and therefore collapsed easily. In addition to utilizing the angiogenic qualities of cytokines, we hope to exploit the growth potentials of stromal cells derived from bone marrow for the production of a clinically practical, bioengineered trachea.
- 1 June 2004
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 39 (3) , 257-262
Generation of a tissue‐engineered tracheal equivalent
In this Minireview we summarize efforts to generate an autologous tissue‐engineered trachea (TET) shaped as a cylinder containing a helix of cartilage to form the structural component of a functional tracheal replacement. Our first step was to demonstrate that a composite engineered tracheal equivalent composed of cartilaginous cylinder could be lined with nasal epithelial cells in a nude‐mouse model. We then demonstrated the feasibility of creating the cartilage and fibrous portion of the trachea using autologous tissue harvested from a single procedure in both nude‐rat and sheep models. Gross morphology and tissue morphology of these TET series were similar to that of native trachea. Histological data indicated the presence of mature cartilage formation of a pseudostratified columnar epithelium and the presence of mature cartilage surrounded by connective tissue, as would be expected of native trachea. Regarding the biomechanical properties, the cartilage was excellent in nude model; however, sheep autologous TET provided less support and therefore collapsed easily. In addition to utilizing the angiogenic qualities of cytokines, we hope to exploit the growth potentials of stromal cells derived from bone marrow for the production of a clinically practical, bioengineered trachea.